BVS
Bioventus Inc - Ordinary Shares - Class A

428
Loading...
Loading...
News
all
press releases
Bioventus (BVS) Misses Q2 Earnings and Revenue Estimates
Bioventus (BVS) delivered earnings and revenue surprises of -4.55% and -0.26%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
More News
News Placeholder
Do Options Traders Know Something About Bioventus Stock We Don't?
Zacks·4mo ago
News Placeholder
Bioventus price target raised by $3 at Craig-Hallum, here's why
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Q4 2023 Bioventus Inc Earnings Call Transcript
Related Stocks: NAS:BVS...
GuruFocus·2y ago
News Placeholder
Bioventus Reports Upbeat Earnings, Joins Ranpak, Beachbody And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones index surging more than 200 points on Tuesday. read more...
Benzinga·2y ago
News Placeholder
Bioventus trading halted, volatility trading pause
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Bioventus sees 2024 non-GAAP EPS 12c-20c, consensus 33c
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Bioventus reports Q4 adjusted EPS 7c, consensus 2c
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Bioventus Non-GAAP EPS of $0.07 beats by $0.05, revenue of $135.42M beats by $11.46M
Bioventus Non-GAAP EPS of $0.07 beats by $0.05, revenue of $135.42M beats by $11.46M...
SeekingAlpha.com: All News·2y ago
News Placeholder
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
Accelerated fourth quarter sales growth to 7.6%, organic growth* of 14.3%Appointed Rob Claypoole as President and Chief Executive Officer, bringing more than 20 years of leadership experience in the...
Globe Newswire·2y ago

Latest BVS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.